JP2013523623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523623A5 JP2013523623A5 JP2013500543A JP2013500543A JP2013523623A5 JP 2013523623 A5 JP2013523623 A5 JP 2013523623A5 JP 2013500543 A JP2013500543 A JP 2013500543A JP 2013500543 A JP2013500543 A JP 2013500543A JP 2013523623 A5 JP2013523623 A5 JP 2013523623A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- compound
- disease
- composition
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 5
- 229940080774 Peroxisome proliferator-activated receptor gamma agonist Drugs 0.000 claims 4
- 208000030159 metabolic disease Diseases 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000007882 Gastritis Diseases 0.000 claims 2
- 108010023302 HDL Cholesterol Proteins 0.000 claims 2
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 102000000536 PPAR gamma Human genes 0.000 claims 2
- 108010016731 PPAR gamma Proteins 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010072170 Skin wound Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 230000036560 skin regeneration Effects 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000770 proinflammatory effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/ES2010/070156 WO2011117429A1 (es) | 2010-03-26 | 2010-03-26 | Derivados quinona de cannabinoides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523623A JP2013523623A (ja) | 2013-06-17 |
| JP2013523623A5 true JP2013523623A5 (enExample) | 2013-09-26 |
| JP5575324B2 JP5575324B2 (ja) | 2014-08-20 |
Family
ID=43087054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013500543A Expired - Fee Related JP5575324B2 (ja) | 2010-03-26 | 2010-03-26 | カンナビノイド・キノン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8772349B2 (enExample) |
| EP (1) | EP2551255B1 (enExample) |
| JP (1) | JP5575324B2 (enExample) |
| ES (1) | ES2657940T3 (enExample) |
| WO (1) | WO2011117429A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014013117A1 (es) * | 2012-07-18 | 2014-01-23 | Consejo Superior De Investigaciones Científicas (Csic) | Cromenopirazoldionas como derivados cannabinoides de quinonas con actividad antitumoral |
| DK2913321T3 (da) * | 2014-02-27 | 2021-10-25 | Emerald Health Pharmaceuticals Inc | Hidtil ukendte cannabigerolderivater |
| ES2548789B1 (es) * | 2014-03-18 | 2016-08-08 | Consejo Superior De Investigaciones Científicas (Csic) | Nuevas cromenoquinonas moduladoras de receptores cannabinoidescb2 con actividad antitumoral |
| CA2945867C (en) * | 2014-04-16 | 2021-11-09 | Vivacell Biotechnology Espana, S.L. | Cannabidiol quinone derivatives |
| CN106860438B (zh) * | 2017-01-23 | 2020-05-22 | 延边大学 | 苯醌衍生物在制备抗肝纤维化药物中的应用 |
| IL269623B2 (en) * | 2017-03-29 | 2025-05-01 | Emerald Health Pharmaceuticals Inc | Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity |
| EP3894384A1 (en) * | 2018-12-11 | 2021-10-20 | Emerald Health Pharmaceuticals Inc. | Cannabigerol quinone acid and salts thereof |
| JP2022524780A (ja) * | 2019-03-12 | 2022-05-10 | イーピーエム（アイピー）， インコーポレイテッド | カンナビノイド酸エステル組成物およびその使用 |
| WO2021111446A1 (en) * | 2019-12-05 | 2021-06-10 | B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Biodegradable polymeric compositions, methods of preparation and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410983B2 (en) * | 2000-10-26 | 2008-08-12 | Fournier Laboratories Ireland Limited | Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| IL159892A0 (en) | 2004-01-15 | 2004-06-20 | Yissum Res Dev Co | Use of quinonoid derivatives of cannabinoids in the treatment of malignancies |
| WO2008107878A1 (en) | 2007-03-05 | 2008-09-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies |
| GB2456183A (en) * | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
-
2010
- 2010-03-26 EP EP10712954.6A patent/EP2551255B1/en not_active Not-in-force
- 2010-03-26 JP JP2013500543A patent/JP5575324B2/ja not_active Expired - Fee Related
- 2010-03-26 ES ES10712954.6T patent/ES2657940T3/es active Active
- 2010-03-26 WO PCT/ES2010/070156 patent/WO2011117429A1/es not_active Ceased
- 2010-03-26 US US13/636,214 patent/US8772349B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523623A5 (enExample) | ||
| AR122395A2 (es) | Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina | |
| JP2013525444A5 (enExample) | ||
| JP2015145426A5 (enExample) | ||
| EA201071298A1 (ru) | Соединение 3-аминокарбазола, фармацевтическая композиция, его содержащая, и способ их получения | |
| JP2014510110A5 (enExample) | ||
| JP2020519654A5 (enExample) | ||
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| WO2010022177A3 (en) | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | |
| JP2012504133A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| EA201892050A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
| JP2013522326A5 (enExample) | ||
| JP2010506953A5 (enExample) | ||
| EP2771307A4 (en) | PROCESS FOR THE PRODUCTION OF ACRYLATES FROM EPOXIDES | |
| JP2015517579A5 (enExample) | ||
| BR112014005389A8 (pt) | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal | |
| NZ712479A (en) | Methods, compounds, and compositions for the treatment of angiotensin-related diseases | |
| JP2013522367A5 (enExample) | ||
| PE20120989A1 (es) | Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo | |
| WO2016105118A3 (ko) | Gpr120 효능제로서의 바이아릴 유도체 | |
| EP2390014A4 (en) | PROCESS FOR OBTAINING AND PRODUCING ETHANOL AND OIL | |
| JP2016540749A5 (enExample) | ||
| EA201590735A1 (ru) | 2-фенил-5-гетероциклил-тетрагидро-2h-пиран-3-аминовые соединения для применения в лечении диабета и связанных с ним расстройств | |
| JP2018521121A5 (enExample) |